Reirradiation for Sinonasal Adenoid Cystic Carcinoma in a Low-Middle Income Setting: A Case Report and Literature Review

Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor’s radio...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Case reports in oncology Ročník 18; číslo 1; s. 1 - 11
Hlavní autori: Kaabia, Wael, Mousli, Alia, Attia, Najla, Naija, Bouchra, Ghorbel, Asma, Ben Zid, Khadija, Zarraa, Semia, Abidi, Rim, Nasr, Chiraz
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Switzerland 01.01.2025
Predmet:
ISSN:1662-6575, 1662-6575
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor’s radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric modulated arc therapy (VMAT) as a feasible reirradiation option in such settings. Case presentation: We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk. The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up nor distant metastasis. Conclusions: This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors where therapeutic options are limited.
AbstractList Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor's radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric-modulated arc therapy (VMAT) as a feasible reirradiation option in such settings. We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk (OAR). The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up or distant metastasis. This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors, where therapeutic options are limited.
Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor's radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric-modulated arc therapy (VMAT) as a feasible reirradiation option in such settings.IntroductionReirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor's radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric-modulated arc therapy (VMAT) as a feasible reirradiation option in such settings.We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk (OAR). The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up or distant metastasis.Case PresentationWe report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk (OAR). The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up or distant metastasis.This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors, where therapeutic options are limited.ConclusionsThis case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors, where therapeutic options are limited.
Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income countries where access to advanced radiation modalities such as proton or carbon ion therapy is limited. Given the tumor’s radioresistant nature and the risk of cumulative toxicity to critical structures, reporting experiences with accessible and precise photon-based techniques remains essential. This case highlights the potential of volumetric modulated arc therapy (VMAT) as a feasible reirradiation option in such settings. Case presentation: We report the case of a 79-year-old male with a history of left ethmoidal sinus ACC initially treated with surgery followed by cobalt-based radiotherapy. Eighteen years later, the patient presented with an inoperable local recurrence. A multidisciplinary tumor board recommended reirradiation using VMAT. A total dose of 60 Gy in 30 fractions was delivered, with careful dosimetric planning to respect cumulative tolerance thresholds of organs at risk. The treatment was well-tolerated, with no acute grade ≥3 toxicities. Post-treatment imaging showed a marked reduction in tumor volume, and the patient had no severe late toxicity during follow-up nor distant metastasis. Conclusions: This case illustrates the potential role of VMAT as a viable reirradiation strategy for head and neck ACC, particularly in resource-limited settings. It emphasizes the importance of individualized treatment planning, accurate dose delivery, and multidisciplinary evaluation in achieving tumor control while minimizing toxicity. Such experiences contribute valuable insights into the management of complex recurrent tumors where therapeutic options are limited.
Author Zarraa, Semia
Attia, Najla
Naija, Bouchra
Kaabia, Wael
Nasr, Chiraz
Ben Zid, Khadija
Ghorbel, Asma
Abidi, Rim
Mousli, Alia
Author_xml – sequence: 1
  givenname: Wael
  orcidid: 0009-0006-1553-8649
  surname: Kaabia
  fullname: Kaabia, Wael
– sequence: 2
  givenname: Alia
  surname: Mousli
  fullname: Mousli, Alia
– sequence: 3
  givenname: Najla
  surname: Attia
  fullname: Attia, Najla
– sequence: 4
  givenname: Bouchra
  surname: Naija
  fullname: Naija, Bouchra
– sequence: 5
  givenname: Asma
  surname: Ghorbel
  fullname: Ghorbel, Asma
– sequence: 6
  givenname: Khadija
  surname: Ben Zid
  fullname: Ben Zid, Khadija
– sequence: 7
  givenname: Semia
  surname: Zarraa
  fullname: Zarraa, Semia
– sequence: 8
  givenname: Rim
  surname: Abidi
  fullname: Abidi, Rim
– sequence: 9
  givenname: Chiraz
  surname: Nasr
  fullname: Nasr, Chiraz
BackLink https://www.ncbi.nlm.nih.gov/pubmed/41063869$$D View this record in MEDLINE/PubMed
BookMark eNpN0U1PwzAMBuAIDbEPOPAHUI5wKCRNk67cpoqPSUNIG5yrtHFRUJuMJGXs39NpY-Jky37kw-sxGhhrAKFLSm4p5dkdIYQnacLiEzSiQsSR4Ckf_OuHaOz9JyEi44KfoWFCiWBTkY3QzxK0c1JpGbQ1uLYOr3R_XnrZ4JkCY7XC-dYHXeFcuqrftRJrgyVe2E30opVqAM9NZVvAKwhBm497POutB7yEtXUBS6PwQgdwMnRuN_3WsDlHp7VsPFwc6gS9Pz685c_R4vVpns8WURVP4xAlVDEuCaOiSgjNSh7LDLIYaigpq1NBaMqVYLRPgEFNSiYYSCIZqVXKesYm6Hp_d-3sVwc-FK32FTSNNGA7X7CYZyQjCaM9vTrQrmxBFWunW-m2xV9aPbjZg8pZ7x3UR0JJsftEcfwE-wUK2XjG
ContentType Journal Article
Copyright 2025 The Author(s). Published by S. Karger AG, Basel.
Copyright_xml – notice: 2025 The Author(s). Published by S. Karger AG, Basel.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1159/000547432
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1662-6575
EndPage 11
ExternalDocumentID 41063869
10_1159_000547432
Genre Journal Article
Case Reports
GroupedDBID ---
0~B
29B
3O.
53G
5GY
5VS
6J9
7X7
8FI
8FJ
AAYXX
ABBTS
ABDBF
ABPAZ
ABUWG
ABWCG
ACGFS
ACUHS
ADBBV
AEGXH
AEYAO
AFKRA
AHFRZ
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZPMC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CAG
CCPQU
CITATION
DIK
E0A
E3Z
EBS
F5P
FB.
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
ITC
KQ8
M--
M~E
O5R
O5S
OK1
PHGZM
PQQKQ
PROAC
RNS
RPM
TR2
UKHRP
4.4
ADRAZ
C1A
COF
CYUIP
EJD
IPNFZ
M48
NPM
RIG
7X8
ID FETCH-LOGICAL-c282t-41d35a0316c4019b52a9e92efeb13f760175d6310053ef0b363ea0a30fd732ef3
ISICitedReferencesCount 0
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001563008000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1662-6575
IngestDate Thu Oct 09 19:01:07 EDT 2025
Sun Oct 12 01:41:05 EDT 2025
Sat Nov 29 07:43:01 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Reirradiation
Volumetric-modulated arc therapy
Tumor recurrence
Low-middle income setting
Head and neck cancer
Radiotherapy
Adenoid cystic carcinoma
Ethmoidal sinus
Language English
License https://creativecommons.org/licenses/by-nc/4.0
2025 The Author(s). Published by S. Karger AG, Basel.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c282t-41d35a0316c4019b52a9e92efeb13f760175d6310053ef0b363ea0a30fd732ef3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0009-0006-1553-8649
OpenAccessLink https://karger.com/cro/article-pdf/doi/10.1159/000547432/4406790/000547432.pdf
PMID 41063869
PQID 3259090431
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_3259090431
pubmed_primary_41063869
crossref_primary_10_1159_000547432
PublicationCentury 2000
PublicationDate 2025-01-01
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Case reports in oncology
PublicationTitleAlternate Case Rep Oncol
PublicationYear 2025
SSID ssj0069565
Score 2.3062184
Snippet Introduction: Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and...
Reirradiation for recurrent adenoid cystic carcinoma (ACC) of the head and neck poses significant clinical challenges, particularly in low- and middle-income...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
StartPage 1
Title Reirradiation for Sinonasal Adenoid Cystic Carcinoma in a Low-Middle Income Setting: A Case Report and Literature Review
URI https://www.ncbi.nlm.nih.gov/pubmed/41063869
https://www.proquest.com/docview/3259090431
Volume 18
WOSCitedRecordID wos001563008000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1662-6575
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069565
  issn: 1662-6575
  databaseCode: DOA
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1662-6575
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069565
  issn: 1662-6575
  databaseCode: M~E
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVKGR
  databaseName: Karger Open Access Journals
  customDbUrl:
  eissn: 1662-6575
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069565
  issn: 1662-6575
  databaseCode: M--
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.karger.com/OpenAccess
  providerName: Karger AG
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1662-6575
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069565
  issn: 1662-6575
  databaseCode: BENPR
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 1662-6575
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0069565
  issn: 1662-6575
  databaseCode: 7X7
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLe6DU27IL4pH5VB3KaIJo6TmFuYipBYq2kM0VvkOI6WqU2qpB3lwn_C_8qznbgtbBIcuFiRbTnWez89vy8_I_TGFXkoOMsdsK5Sx_c4fKWCOZFgri_SPBcy049NhJNJNJ2ys17vZ3cX5noWlmW0XrPFf2U19AGz1dXZf2C3XRQ64BuYDi2wHdq_Yvy5LOpaVRywWYSfC7DxeaOYAVKmKrLjk--qPLPK9hAwNufK68GPT6tvzlg7LJTYqOYSJMmyuxEdw-xGtgq7Djmc2orM2xEGW_WgkTYgAatXpdhx4H_iPDV5ul-7rH2d-rtqzH3teFbYAyOGTXBzFFzNbO-EF1fm3ehqJS5rvu2_8OiW_8KI3CDwVAKOiW3LG_r-kNMWj0boglLr3XwaUGbSJ6kPitLOHCDcYq4R4LtKazPvxfxWersb2kMHXkiZyhgc_xh1B30ApqXKkLWbbQtXwV_f2n8eocNulV3N5xZzRqs1F_fQ3dYewbHB0X3Uk-UDdDhuMy4eovUOnDDACVs44RZO2MAJWzjhosQcb-CEDZxwC6d3OMYKH9iACQOY8AZM2IDpEfryYXRx8tFpX-twBJjtS8d3M0I5nBGBAJudpdTjTDJP5qANkFylXoU0C1Q8iRKZD1MSEMmHnAzzLCQwjTxG-7B9-RRh4kdUBsJNKZd-lOZRREENDsC4ISBCIrePXneUTBamKEuijVnKEkv5PnrV0TgBkaniYLyUAOOEgMk_ZKqqVB89McS3y3TMenbryHN0tIHxC7S_rFfyJbojrpdFUw_QXjgNdRsN0MH70eTsfKD9PAONnV_p3pJd
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reirradiation+for+Sinonasal+Adenoid+Cystic+Carcinoma+in+a+Low-Middle+Income+Setting%3A+A+Case+Report+and+Literature+Review&rft.jtitle=Case+reports+in+oncology&rft.au=Kaabia%2C+Wael&rft.au=Mousli%2C+Alia&rft.au=Attia%2C+Najla&rft.au=Naija%2C+Bouchra&rft.date=2025-01-01&rft.issn=1662-6575&rft.eissn=1662-6575&rft.volume=18&rft.issue=1&rft.spage=1152&rft_id=info:doi/10.1159%2F000547432&rft_id=info%3Apmid%2F41063869&rft.externalDocID=41063869
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-6575&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-6575&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-6575&client=summon